Liver Transplantation: From Child to MELD

Medical Clinics of North America

Volumn 93, Issue 4, 2009, Pages 931-950

  Gallegos Orozco, Juan F ^a   Vargas, Hugo E ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cirrhosis; Hepatocellular carcinoma; Liver disease; Liver transplantation; Viral hepatitis

Indexed keywords

ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; IMMUNOSUPPRESSIVE AGENT; TERLIPRESSIN;

AGE DISTRIBUTION; ALCOHOL LIVER DISEASE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; GRAFT VERSUS HOST REACTION; HEPATITIS C; HEPATORENAL SYNDROME; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; KIDNEY DISEASE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONOR; LUNG DISEASE; OBESITY; PATIENT SELECTION; PERIOPERATIVE PERIOD; PRIMARY BILIARY CIRRHOSIS; PRIMARY MEDICAL CARE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SOCIAL PSYCHOLOGY; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT CONTRAINDICATION;

CARCINOMA, HEPATOCELLULAR; COMMUNICABLE DISEASES; COMORBIDITY; HEALTH STATUS INDICATORS; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER CIRRHOSIS, BILIARY; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; LUNG DISEASES; NEOPLASMS; PATIENT SELECTION; PROGNOSIS; REFERRAL AND CONSULTATION; RESOURCE ALLOCATION; SEVERITY OF ILLNESS INDEX; TISSUE AND ORGAN PROCUREMENT;

EID: 67649414283     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2009.03.010     Document Type: Review

References (136)

1. Ahmed A., and Keeffe E.B. Current indications and contraindications for liver transplantation. Clin Liver Dis 11 2 (2007) 227-247
2. Tome S., Wells J.T., Said A., et al. Quality of life after liver transplantation. A systematic review. J Hepatol 48 4 (2008) 567-577
3. Kim W.R., Brown Jr. R.S., Terrault N.A., et al. Burden of liver disease in the United States: summary of a workshop. Hepatology 36 1 (2002) 227-242
4. Olivera-Martinez M.A., and Gallegos-Orozco J.F. Recurrent viral liver disease (hepatitis B and C) after liver transplantation. Arch Med Res 38 6 (2007) 691-701
5. Sharma P., and Lok A. Viral hepatitis and liver transplantation. Semin Liver Dis 26 3 (2006) 285-297
6. Roche B., and Samuel D. Aspects of hepatitis C virus infection relating to liver transplantation. Eur J Gastroenterol Hepatol 18 4 (2006) 313-320
7. Rodriguez-Luna H., and Vargas H.E. Management of hepatitis C virus infection in the setting of liver transplantation. Liver Transpl 11 5 (2005) 479-489
8. Seeff L.B., Miller R.N., Rabkin C.S., et al. 45-Year follow-up of hepatitis C virus infection in healthy young adults. Ann Intern Med 132 2 (2000) 105-111
9. Befeler A.S., and Di Bisceglie A.M. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 122 6 (2002) 1609-1619
10. Murray K.F., and Carithers Jr. R.L. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology 41 6 (2005) 1407-1432
11. Berenguer M. Natural history of recurrent hepatitis C. Liver Transpl 8 10 Suppl 1 (2002) S14-S18
12. Berenguer M., Ferrell L., Watson J., et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 32 4 (2000) 673-684
13. Charlton M. Patient and graft survival following liver transplantation for hepatitis C: much ado about something. Gastroenterology 122 4 (2002) 1162-1165
14. Forman L.M., Lewis J.D., Berlin J.A., et al. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 122 4 (2002) 889-896
15. Everson G.T., Trotter J., Forman L., et al. Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy. Hepatology 42 2 (2005) 255-262
16. Verna E.C., and Brown Jr. R.S. Hepatitis C and liver transplantation: enhancing outcomes and should patients be retransplanted. Clin Liver Dis 12 3 (2008) 637-659 ix-x
17. Riediger C., Berberat P.O., Sauer P., et al. Prophylaxis and treatment of recurrent viral hepatitis after liver transplantation. Nephrol Dial Transplant 22 Suppl 8 (2007) viii37-viii46
18. Triantos C., Samonakis D., Stigliano R., et al. Liver transplantation and hepatitis C virus: systematic review of antiviral therapy. Transplantation 79 3 (2005) 261-268
19. Encke J., Kraus T., Mehrabi A., et al. Treatment of hepatitis C virus reinfection after liver transplantation. Transplantation 80 1 Suppl (2005) S125-S127
20. Borowsky S.A., Strome S., and Lott E. Continued heavy drinking and survival in alcoholic cirrhotics. Gastroenterology 80 6 (1981) 1405-1409
21. Powell Jr. W.J., and Klatskin G. Duration of survival in patients with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease. Am J Med 44 3 (1968) 406-420
22. Everhart J.E., and Beresford T.P. Liver transplantation for alcoholic liver disease: a survey of transplantation programs in the United States. Liver Transpl Surg 3 3 (1997) 220-226
23. Campbell Jr. D.A., Magee J.C., Punch J.D., et al. One center's experience with liver transplantation: alcohol use relapse over the long-term. Liver Transpl Surg 4 5 Suppl 1 (1998) S58-S64
24. Lucey M.R. Is liver transplantation an appropriate treatment for acute alcoholic hepatitis?. J Hepatol 36 6 (2002) 829-831
25. Lucey M.R. Liver transplantation for alcoholic liver disease. Clin Liver Dis 11 2 (2007) 283-289
26. Belle S.H., Beringer K.C., and Detre K.M. Liver transplantation for alcoholic liver disease in the United States: 1988 to 1995. Liver Transpl Surg 3 3 (1997) 212-219
27. Pereira S.P., and Williams R. Liver transplantation for alcoholic liver disease at King's College Hospital: survival and quality of life. Liver Transpl Surg 3 3 (1997) 245-250
28. Roberts M.S., Angus D.C., Bryce C.L., et al. Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl 10 7 (2004) 886-897
29. Wiesner R.H., Lombardero M., Lake J.R., et al. Liver transplantation for end-stage alcoholic liver disease: an assessment of outcomes. Liver Transpl Surg 3 3 (1997) 231-239
30. Bellamy C.O., DiMartini A.M., Ruppert K., et al. Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence. Transplantation 72 4 (2001) 619-626
31. Lee R.G. Recurrence of alcoholic liver disease after liver transplantation. Liver Transpl Surg 3 3 (1997) 292-295
32. 2007 Annual report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1997-2006 (2007), Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville (MD)
33. Heathcote E.J. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology 31 4 (2000) 1005-1013
34. Neuberger J. Liver transplantation for primary biliary cirrhosis: indications and risk of recurrence. J Hepatol 39 2 (2003) 142-148
35. Liermann Garcia R.F., Evangelista Garcia C., McMaster P., et al. Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center. Hepatology 33 1 (2001) 22-27
36. Abu-Elmagd K.M., Balan V., Abu-Elmagd K.M., et al. Recurrent primary sclerosing cholangitis: from an academic illusion to a clinical reality. [comment]. Liver Transpl 11 11 (2005) 1326-1328
37. Graziadei I.W., Wiesner R.H., Marotta P.J., et al. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology 30 5 (1999) 1121-1127
38. Goss J.A., Shackleton C.R., Farmer D.G., et al. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg 225 5 (1997) 472-481 [discussion: 481-3]
39. Narumi S., Roberts J.P., Emond J.C., et al. Liver transplantation for sclerosing cholangitis. Hepatology 22 2 (1995) 451-457
40. Maheshwari A., Yoo H.Y., Thuluvath P.J., et al. Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC. Am J Gastroenterol 99 3 (2004) 538-542
41. Graziadei I.W., and Graziadei I.W. Recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 8 7 (2002) 575-581
42. Fabia R., Levy M.F., Testa G., et al. Colon carcinoma in patients undergoing liver transplantation. Am J Surg 176 3 (1998) 265-269
43. Loftus Jr. E.V., Aguilar H.I., Sandborn W.J., et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation. Hepatology 27 3 (1998) 685-690
44. El-Serag H.B., Davila J.A., Petersen N.J., et al. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 139 10 (2003) 817-823
45. Hassan M.M., Frome A., Patt Y.Z., et al. Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States. J Clin Gastroenterol 35 3 (2002) 266-269
46. El-Serag H.B., and Mason A.C. Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 160 21 (2000) 3227-3230
47. Llovet J.M., Schwartz M., and Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 25 2 (2005) 181-200
48. Mazzaferro V., Chun Y.S., Poon R.T., et al. Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol 15 4 (2008) 1001-1007
49. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 11 (1996) 693-699
50. Yoo H.Y., Patt C.H., Geschwind J.F., et al. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time. J Clin Oncol 21 23 (2003) 4329-4335
51. Mazzaferro V. Results of liver transplantation: with or without Milan criteria?. Liver Transpl 13 11 Suppl 2 (2007) S44-S47
52. Everson G.T., and Membreno F.E. Liver transplantation: indications, contraindications and results. In: Rodés J., Benhamou J.P., Blei A., et al. (Eds). Textbook of hepatology: from basic science to clinical practice. 3rd edition (2007), Blackwell Publishing, Oxford 1984-1995
53. Sharma P., and Rakela J. Management of pre-liver transplantation patients - part 1. Liver Transpl 11 2 (2005) 124-133
54. Keswani R.N., Ahmed A., and Keeffe E.B. Older age and liver transplantation: a review. Liver Transpl 10 8 (2004) 957-967
55. Carey W.D., Dumot J.A., Pimentel R.R., et al. The prevalence of coronary artery disease in liver transplant candidates over age 50. Transplantation 59 6 (1995) 859-864
56. Donovan C.L., Marcovitz P.A., Punch J.D., et al. Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation. Transplantation 61 8 (1996) 1180-1188
57. Keeffe E.B. Summary of guidelines on organ allocation and patient listing for liver transplantation. Liver Transpl Surg 4 5 Suppl 1 (1998) S108-S114
58. Keeffe E.B. Update on liver transplantation. Rev Gastroenterol Mex 69 Suppl 3 (2004) 160-170
59. Krowka M.J. Hepatopulmonary syndrome: recent literature (1997 to 1999) and implications for liver transplantation. Liver Transpl 6 4 Suppl 1 (2000) S31-S35
60. Krowka M.J. Hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation. Clin Chest Med 26 4 (2005) 587-597 vi
61. Arguedas M.R., Abrams G.A., Krowka M.J., et al. Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology 37 1 (2003) 192-197
62. Krowka M.J., Porayko M.K., Plevak D.J., et al. Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: case reports and literature review. Mayo Clin Proc 72 1 (1997) 44-53
63. Colle I.O., Moreau R., Godinho E., et al. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study. Hepatology 37 2 (2003) 401-409
64. Mucke H.A. Pulmonary arterial hypertension: on the way to a manageable disease. Curr Opin Investig Drugs 9 9 (2008) 957-962
65. Ramsay M.A. Portopulmonary hypertension and hepatopulmonary syndrome, and liver transplantation. Int Anesthesiol Clin 44 3 (2006) 69-82
66. Nair S., Verma S., and Thuluvath P.J. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 35 5 (2002) 1179-1185
67. Lafayette R.A., Pare G., Schmid C.H., et al. Pretransplant renal dysfunction predicts poorer outcome in liver transplantation. Clin Nephrol 48 3 (1997) 159-164
68. Storm C., Bernhardt W.M., Schaeffner E., et al. Immediate recovery of renal function after orthotopic liver transplantation in a patient with hepatorenal syndrome requiring hemodialysis for more than 8 months. Transplant Proc 39 2 (2007) 544-546
69. Richardson D., Stoves J., Davies M.H., et al. Liver transplantation for dialysis dependent hepatorenal failure. Nephrol Dial Transplant 14 11 (1999) 2742-2745
70. Martin-Llahi M., Pepin M.N., Guevara M., et al. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology 134 5 (2008) 1352-1359
71. Sanyal A.J., Boyer T., Garcia-Tsao G., et al. A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology 134 5 (2008) 1360-1368
72. Nair S., Verma S., and Thuluvath P.J. Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology 35 1 (2002) 105-109
73. John P.R., and Thuluvath P.J. Outcome of liver transplantation in patients with diabetes mellitus: a case-control study. Hepatology 34 5 (2001) 889-895
74. Shields P.L., Tang H., Neuberger J.M., et al. Poor outcome in patients with diabetes mellitus undergoing liver transplantation. Transplantation 68 4 (1999) 530-535
75. Neff G.W., Sherman K.E., Eghtesad B., et al. Review article: current status of liver transplantation in HIV-infected patients. Aliment Pharmacol Ther 20 10 (2004) 993-1000
76. Roland M.E., Adey D., Carlson L.L., et al. Kidney and liver transplantation in HIV-infected patients: case presentations and review. AIDS Patient Care STDS 17 10 (2003) 501-507
77. Roland M.E., and Stock P.G. Liver transplantation in HIV-infected recipients. Semin Liver Dis 26 3 (2006) 273-284
78. Ahmed A., and Keeffe E.B. Pretransplant evaluation and care. In: Boyer T.D., Wright T.L., and Manns M.P. (Eds). Zakim and Boyer's hepatology: a textbook of liver disease. 5th edition (2006), Saunders Elsevier, Philadelphia 933-945
79. Manzanet G., Sanjuan F., Orbis P., et al. Liver transplantation in patients with portal vein thrombosis. Liver Transpl 7 2 (2001) 125-131
80. Yerdel M.A., Gunson B., Mirza D., et al. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation 69 9 (2000) 1873-1881
81. Fattovich G., Giustina G., Degos F., et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 112 2 (1997) 463-472
82. Freeman R.B.J. Selection and timing of liver transplantation. In: Schiff E.R., Sorrel M.F., and Maddrey W.C. (Eds). Schiff's diseases of the liver. 10th edition (2007), Lippincott Williams & Wilkins, Philadelphia 1453-1465
83. Consensus conference: Indications for Liver Transplantation, January 19 and 20, 2005, Lyon-Palais Des Congres: text of recommendations (long version). Liver Transpl 12 6 (2006) 998-1011
84. [Consensus document of the Spanish Society of Liver Transplantation]. Gastroenterol Hepatol 31 2 (2008) 82-91 [in Spanish]
85. Koffron A., and Stein J.A. Liver transplantation: indications, pretransplant evaluation, surgery, and posttransplant complications. Med Clin North Am 92 4 (2008) 861-888 ix
86. Plotkin J.S., Benitez R.M., Kuo P.C., et al. Dobutamine stress echocardiography for preoperative cardiac risk stratification in patients undergoing orthotopic liver transplantation. Liver Transpl Surg 4 4 (1998) 253-257
87. Plotkin J.S., Johnson L.B., Rustgi V., et al. Coronary artery disease and liver transplantation: the state of the art. Liver Transpl 6 4 Suppl 1 (2000) S53-S56
88. Freeman Jr. R.B. The model for end-stage liver disease comes of age. Clin Liver Dis 11 2 (2007) 249-263
89. Wiesner R.H. Patient selection in an era of donor liver shortage: current US policy. Nat Clin Pract Gastroenterol Hepatol 2 1 (2005) 24-30
90. Gish R.G. Do we need to MEND the MELD?. Liver Transpl 13 4 (2007) 486-487
91. Pugh R.N., Murray-Lyon I.M., Dawson J.L., et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60 8 (1973) 646-649
92. Malinchoc M., Kamath P.S., Gordon F.D., et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31 4 (2000) 864-871
93. Kamath P.S., Wiesner R.H., Malinchoc M., et al. A model to predict survival in patients with end-stage liver disease. Hepatology 33 2 (2001) 464-470
94. Salerno F., Merli M., Cazzaniga M., et al. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol 36 4 (2002) 494-500
95. Wiesner R., Edwards E., Freeman R., et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124 1 (2003) 91-96
96. McDiarmid S.V., Anand R., and Lindblad A.S. Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation. Transplantation 74 2 (2002) 173-181
97. Freeman Jr. R.B., Wiesner R.H., Harper A., et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 8 9 (2002) 851-858
98. Freeman R.B., Wiesner R.H., Edwards E., et al. Results of the first year of the new liver allocation plan. Liver Transpl 10 1 (2004) 7-15
99. Merion R.M., Rush S.H., Dykstra D.M., et al. Predicted lifetimes for adult and pediatric split liver versus adult whole liver transplant recipients. Am J Transplant 4 11 (2004) 1792-1797
100. Wiesner R.H. Evidence-based evolution of the MELD/PELD liver allocation policy. Liver Transpl 11 3 (2005) 261-263
101. Freeman R.B., Gish R.G., Harper A., et al. Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD exception study group and conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula. Liver Transpl 12 12 Suppl 3 (2006) S128-S136
102. Cholongitas E., Marelli L., Shusang V., et al. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl 12 7 (2006) 1049-1061
103. Cholongitas E., Papatheodoridis G.V., Vangeli M., et al. Systematic review: the model for end-stage liver disease-should it replace Child-Pugh's classification for assessing prognosis in cirrhosis?. Aliment Pharmacol Ther 22 11-12 (2005) 1079-1089
104. Biggins S.W., Rodriguez H.J., Bacchetti P., et al. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology 41 1 (2005) 32-39
105. Heuman D.M., Abou-Assi S.G., Habib A., et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 40 4 (2004) 802-810
106. Ruf A.E., Kremers W.K., Chavez L.L., et al. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 11 3 (2005) 336-343
107. Stewart C.A., Malinchoc M., Kim W.R., et al. Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl 13 10 (2007) 1366-1371
108. Lucey M.R. How will patients be selected for transplantation in the future?. Liver Transpl 10 10 Suppl 2 (2004) S90-S92
109. Haydon G.H., Hiltunen Y., Lucey M.R., et al. Self-organizing maps can determine outcome and match recipients and donors at orthotopic liver transplantation. Transplantation 79 2 (2005) 213-218
110. Wachs M.E., Bak T.E., Karrer F.M., et al. Adult living donor liver transplantation using a right hepatic lobe. Transplantation 66 10 (1998) 1313-1316
111. Florman S., and Miller C.M. Live donor liver transplantation. Liver Transpl 12 4 (2006) 499-510
112. Brown Jr. R.S., Russo M.W., Lai M., et al. A survey of liver transplantation from living adult donors in the United States. N Engl J Med 348 9 (2003) 818-825
113. Brown Jr. R.S. Live donors in liver transplantation. Gastroenterology 134 6 (2008) 1802-1813
114. Renz J.F., and Busuttil R.W. Adult-to-adult living-donor liver transplantation: a critical analysis. Semin Liver Dis 20 4 (2000) 411-424
115. Tuttle-Newhall J.E., Collins B.H., Desai D.M., et al. The current status of living donor liver transplantation. Curr Probl Surg 42 3 (2005) 144-183
116. Kim-Schluger L., Florman S.S., Schiano T., et al. Quality of life after lobectomy for adult liver transplantation. Transplantation 73 10 (2002) 1593-1597
117. Miyagi S., Kawagishi N., Fujimori K., et al. Risks of donation and quality of donors' life after living donor liver transplantation. Transpl Int 18 1 (2005) 47-51
118. Trotter J.F., Talamantes M., McClure M., et al. Right hepatic lobe donation for living donor liver transplantation: impact on donor quality of life. Liver Transpl 7 6 (2001) 485-493
119. Chan S.C., Liu C.L., Lo C.M., et al. Donor quality of life before and after adult-to-adult right liver live donor liver transplantation. Liver Transpl 12 10 (2006) 1529-1536
120. Trotter J.F., Campsen J., Bak T., et al. Outcomes of donor evaluations for adult-to-adult right hepatic lobe living donor liver transplantation. Am J Transplant 6 8 (2006) 1882-1889
121. Trotter J.F., Wisniewski K.A., Terrault N.A., et al. Outcomes of donor evaluation in adult-to-adult living donor liver transplantation. Hepatology 46 5 (2007) 1476-1484
122. Berg C.L., Gillespie B.W., Merion R.M., et al. Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology 133 6 (2007) 1806-1813
123. Fisher R.A., Kulik L.M., Freise C.E., et al. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant 7 6 (2007) 1601-1608
124. Guo L., Orrego M., Rodriguez-Luna H., et al. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients. Liver Transpl 12 4 (2006) 560-565
125. Kulik L., and Abecassis M. Living donor liver transplantation for hepatocellular carcinoma. Gastroenterology 127 5 Suppl 1 (2004) S277-S282
126. Lo C.M., Fan S.T., Liu C.L., et al. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg 94 1 (2007) 78-86
127. Shiffman M.L., Stravitz R.T., Contos M.J., et al. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation. Liver Transpl 10 10 (2004) 1248-1255
128. Terrault N.A., and Berenguer M. Treating hepatitis C infection in liver transplant recipients. Liver Transpl 12 8 (2006) 1192-1204
129. Bak T., Wachs M., Trotter J., et al. Adult-to-adult living donor liver transplantation using right-lobe grafts: results and lessons learned from a single-center experience. Liver Transpl 7 8 (2001) 680-686
130. Fan S.T. Live donor liver transplantation in adults. Transplantation 82 6 (2006) 723-732
131. Ghobrial R.M., Saab S., Lassman C., et al. Donor and recipient outcomes in right lobe adult living donor liver transplantation. Liver Transpl 8 10 (2002) 901-909
132. Miller C.M., Gondolesi G.E., Florman S., et al. One hundred nine living donor liver transplants in adults and children: a single-center experience. Ann Surg 234 3 (2001) 301-311 [discussion: 311-2]
133. Marcos A., Fisher R.A., Ham J.M., et al. Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. Transplantation 69 7 (2000) 1375-1379
134. Kawasaki S., Makuuchi M., Ishizone S., et al. Liver regeneration in recipients and donors after transplantation. Lancet 339 8793 (1992) 580-581
135. Nakagami M., Morimoto T., Itoh K., et al. Patterns of restoration of remnant liver volume after graft harvesting in donors for living related liver transplantation. Transplant Proc 30 1 (1998) 195-199
136. Akamatsu N., Sugawara Y., Kaneko J., et al. Effects of middle hepatic vein reconstruction on right liver graft regeneration. Transplantation 76 5 (2003) 832-837